HSR&D Research Career Scientist Award
高铁
基本信息
- 批准号:10535424
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-10-01 至 2025-09-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdmission activityAntibioticsAntimicrobial ResistanceAreaAustraliaAwardBiometryCanadaCaringCathetersChinaChronicCollaborationsCommunicable DiseasesComplexCountryDiscipline of NursingDiseaseDoctor of PhilosophyEngineeringEpidemiologistEpidemiologyFranceGermanyGoalsGovernmentGuidelinesHealth ServicesHealthcareHomogeneously Staining RegionHospitalizationInfectionInfection ControlJournalsMaster of ScienceMedical centerMedicineMentorsMethodologyMethodsMissionMonitorMorbidity - disease rateMulti-Drug ResistanceNetherlandsOutcomePaperPatient CarePatientsPeer ReviewPersonsPoliciesPopulationPreventionPrincipal InvestigatorPublicationsPublishingRegistriesResearchResearch ActivityResearch DesignResearch PersonnelResearch SupportRisk FactorsScienceScientistServicesSourceSpainSpinal CordSpinal cord injuryStatistical Data InterpretationStudentsSwitzerlandTechniquesTechnologyTrainingUnited KingdomUnited StatesUniversitiesVeteransWorkcareercompare effectivenessdata warehousehealthcare-associated infectionshigh riskimplementation scienceimprovedinfection managementinfection riskinnovationmembermethicillin resistant Staphylococcus aureusmodifiable riskmortalitymulti-drug resistant pathogenmultidisciplinarypatient populationprogramsresearch studystudent mentoringtooltreatment and outcomeurinary
项目摘要
I have been conducting research in health services, epidemiology, and implementation science at the Hines
VA Medical Center, HSR&D Center of Innovation for Complex Chronic Healthcare (CINCCH) for over 19
years. My primary area of research has focused on Veterans with SCI/D, whom are at increased risk for
infections and acquiring multidrug resistant organisms (MDROs). Little research had been conducted in this
patient population, particularly in the VA which is the single largest source of care for persons with SCI/D in
the U.S. My research has made significant impacts on the care of Veterans with SCI/D. This includes
developing and disseminating a toolkit on prevention of methicillin-resistant Staphylococcus aureus (MRSA)
colonization/infection for patients with SCI/D; educating clinicians about the modifiable risk factors of
MDROs and impacts on morbidity and mortality in this population, and working collaboratively with clinicians
and investigators across the country to develop tools for monitoring and tracking outcomes in Veterans with
SCI/D, including the new VHA SCI/D outcomes registry. I have also expanded this work to a broader VA
population including leading a QUERI program on antimicrobial resistance. Overall, this portfolio of research
has led to 119 publications (45 first/senior author) and national prestige as a recipient of the Presidential
Early Career Award for Scientists and Engineers (PECASE) in 2012, awarded by the United States
president and White House Office of Science and Technology Policy. In addition, as a doctoral level
epidemiologist, my methodological training has allowed me to support the research activities of
collaborators across the country. I also conduct mentoring activities for both clinician and non-clinician
investigators, fellows, and students and participate in service activities for both VA and non-VA workgroups
and committees. This award will be used to: 1) conduct and disseminate research that improves the health
care and outcomes of Veterans, with a particular focus on prevention and management of infections and
MDROs; 2) support the quantitative training and mentoring of students, fellows, and early career
investigators; and 3) provide service to local and national committees to support the mission of VA, the
HSR&D program, and CINCCH.
我一直在Hines进行卫生服务,流行病学和实施科学研究
VA医疗中心,霍斯和D复杂慢性医疗保健创新中心(CINCCH)超过19
年。我的主要研究领域集中于SCI/D的退伍军人,他们的风险增加
感染和获取多药抗性生物(MDROS)。对此几乎没有研究
患者群体,特别是在VA中,这是SCI/D的人的最大护理来源
美国我的研究对具有SCI/D的退伍军人的护理产生了重大影响。这包括
开发和传播有关预防耐甲氧西林金黄色葡萄球菌(MRSA)的工具包
SCI/D患者的定殖/感染;教育临床医生有关可修改的风险因素
MDRO和对该人群中发病率和死亡率的影响,并与临床医生合作
以及全国各地的调查人员开发用于监视和跟踪退伍军人成果的工具
SCI/D,包括新的VHA SCI/D成果注册表。我还将这项工作扩展到了更广泛的VA
人口包括领导抗菌耐药性的QuERI计划。总体而言,这项研究组合
已导致119个出版物(45位/高级作家)和国家声望作为总统的接受者
美国授予的2012年科学家和工程师的早期职业奖(PECASE)
总裁兼白宫科学技术政策办公室。另外,作为博士学位
流行病学家,我的方法论培训使我能够支持
全国各地的合作者。我还为临床医生和非临床医生开展指导活动
调查人员,研究员和学生,并参加VA和非VA工作组的服务活动
和委员会。该奖项将用于:1)进行和传播研究以改善健康状况
退伍军人的关怀和成果,特别着眼于预防和管理感染和管理
mdros; 2)支持学生,研究员和早期职业的定量培训和指导
调查人员; 3)为地方和国家委员会提供服务,以支持VA的使命
HSR&D程序,以及Cincch。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLESNIKA T EVANS其他文献
CHARLESNIKA T EVANS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLESNIKA T EVANS', 18)}}的其他基金
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
视频会议抗菌管理团队 (VAST) 的传播和实施
- 批准号:
10672768 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
视频会议抗菌管理团队 (VAST) 的传播和实施
- 批准号:
10620614 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
视频会议抗菌管理团队 (VAST) 的传播和实施
- 批准号:
10312278 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
通过快速实施现有指南和证据来对抗抗菌素耐药性 (CARRIAGE)
- 批准号:
10187395 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
感染耐药革兰氏阴性菌的退伍军人的治疗效果和结果。
- 批准号:
10186505 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
感染耐药革兰氏阴性菌的退伍军人的治疗效果和结果。
- 批准号:
9502631 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
感染耐药革兰氏阴性菌的退伍军人的治疗效果和结果。
- 批准号:
9695865 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
通过快速实施现有指南和证据来对抗抗菌素耐药性 (CARRIAGE)
- 批准号:
9205309 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
通过快速实施现有指南和证据来对抗抗菌素耐药性 (CARRIAGE)
- 批准号:
10200821 - 财政年份:2016
- 资助金额:
-- - 项目类别:
相似海外基金
31st Meeting of the American Society for Rickettsiology
美国立克次体学会第31次会议
- 批准号:
10469039 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Deep-CDS: Deep Learning Semantic Data Lake for Clinical Decision Support
Deep-CDS:用于临床决策支持的深度学习语义数据湖
- 批准号:
10546333 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Quantifying the Cardiovascular and Immunologic Changes after Spinal Cord Injury to Aid Diagnosis of Clinically Meaningful Infections
量化脊髓损伤后的心血管和免疫变化,以帮助诊断有临床意义的感染
- 批准号:
10380502 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Quantifying the Cardiovascular and Immunologic Changes after Spinal Cord Injury to Aid Diagnosis of Clinically Meaningful Infections
量化脊髓损伤后的心血管和免疫变化,以帮助诊断有临床意义的感染
- 批准号:
10577881 - 财政年份:2022
- 资助金额:
-- - 项目类别: